The Group comprises a Point-of-Care Division in Oslo and a Laboratory Division in Dundee.
In the laboratory sector we specialise in proprietary markers for the early diagnosis and management of critical illnesses such as cardiovascular and neurodegenerative diseases, rheumatoid arthritis and diabetes. We are playing an increasingly leading role in the fight against the global diabetes epidemic, and the need to keep tight control over blood glucose levels to avoid serious clinical sequelae.
We have a special skill in adapting our markers to the automated analyser systems of the global IVD companies which dominate the hospital laboratory sector.
We firmly believe that our products provide clinicians and other healthcare professionals with tools to deliver better patient care. Early, rapid and differential diagnosis of disease in the presence of the patient facilitates the best treatment options and is being increasingly recognised as an essential component of more effective primary care.
A pioneering organisation focused on the development and manufacturing of important and innovative in vitro diagnostic tests for use in clinical laboratories and at the point of care.
As a general marker of overall health status, few tests carry greater predictive weight than Homocysteine. The amount of Homocysteine in your blood is one of the best independent indicators of how healthy you are.